Oral Answers to Questions Debate

Full Debate: Read Full Debate
Department: Cabinet Office

Oral Answers to Questions

Yasmin Qureshi Excerpts
Wednesday 16th January 2019

(5 years, 3 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Theresa May Portrait The Prime Minister
- Hansard - - - Excerpts

First, I commend my hon. Friend for the work she is doing in her constituency through the jobs fairs. I absolutely agree with her: it is very important that young people are able to see that there are different routes for them for their futures and different routes into the workplace. Apprenticeships are an important route for some young people. All the apprentices that I meet say that the best thing they have done is take up an apprenticeship, and that was right for them. We want every young person to be able to take the route that is right for them, be it higher education, further education or apprenticeships.

Yasmin Qureshi Portrait Yasmin Qureshi (Bolton South East) (Lab)
- Hansard - -

Q6. In the ’60s and ’70s, 1.2 million Primodos pills were prescribed to women, including three of my constituents. Each dosage was equivalent to 40 oral contraceptive pills. Thousands of babies were born with deformities. A recent Medicines and Healthcare Products Regulatory Agency review was widely criticised for being a whitewash. Now Professor Carl Heneghan of Oxford University has published a review of the scientific data that clearly shows that Primodos did cause deformities. Will the Prime Minister ensure that any response to the review does not involve the MHRA, as we have no faith in it?

Theresa May Portrait The Prime Minister
- Hansard - - - Excerpts

This is an important issue that has been raised by a number of Members from across the House. Our priority is always the safety of patients. Ministers are aware of the new study that has come out. We have a commitment to review any new evidence in this area, and we do that, but we do it by consulting independent scientific experts. Baroness Cumberledge is leading the independent medicines and medical devices safety review. That is expected to examine what happened in the case of Primodos and will determine what further action is needed. I assure the hon. Lady that we will listen very carefully to any recommendations that come out of the review, and of course that study will be looked at very carefully to see what has come out of it.